Genetic stasis of dominant West Nile virus genotype, Houston, Texas.
Previous phylogenetic analyses of North American West Nile virus (WNV) isolates have shown genetically distinct variants that group in a temporally and geographically dependent manner (1). Recent studies have provided substantial evidence that a dominant genetic variant has emerged across much, if not all, of North America (2-4). The establishment of a dominant genotype across the continent and the displacement and possible extinction of earlier progenitor genotypes appear to have resulted from the accumulation and fixation of multiple nucleotide mutations throughout the WNV genome. Despite the occurrence of 13 conserved nucleotide mutations (out of 11,029 nt/genome) in isolates belonging to the dominant genotype, only 1 of these mutations, E-1442(U to C); E159(Val to Ala), resulted in an amino acid substitution (out of 3,433 amino acids/polyprotein). Consequently, a scarcity of non-synonymous mutations in the dominant genotype compared with progenitor genotypes has made it difficult to evaluate and quantify any relative fitness advantages possessed by the dominant strains (5, 6).
The rapid emergence of the dominant genotype across North America and subsequent displacement of other genotypes suggested an apparent fitness advantage conferred by mutations in the genome of the dominant variants. In fact, studies by Ebel et al. suggest that the dominant genotype is transmitted by Culex pipiens after fewer days of extrinsic incubation than are needed by the prototypical strain, WN-NY99, leading to a possible increase in the transmission efficiency of the dominant genotype (6). The proliferation of this genotype over such a relatively short period ([approximately equal to] 3 years, from the summer of 1999 through the summer of 2002) and vast geographic scale has led us to consider whether the genetic divergence of the virus has continued at a similar rate. To further characterize the evolutionary patterns of WNV, we chose to focus on a readily available population of virus isolates that provide a representation of the current state of WNV evolution at a localized level.
The 44 WNV isolates included in this study were obtained in the Houston, Texas, metropolitan area during the course of 5 years (2002-2006). All of the 25 earlier isolates and 19 newly sequenced isolates came from dead birds or mosquitoes and were isolated as previously described (7). The complete premembrane (prM) and envelope (E) protein genes (2004 nucleotides) were sequenced by reverse transcription-PCR (RT-PCR) with RNA extracted from cell culture supernatant of either the original isolation or after a single passage in Vero cells. RT-PCR protocols, primer sequences, and sequencing methods have been described elsewhere and are available on request (1). Nucleotide and deduced amino acid sequences of all isolates were aligned with the prototypical North American WNV, WN-NY99, by using AlignX in the VectorNTI software package (Informax, Frederick, MD, USA). The year, source, and corresponding GenBank accession number for each isolate are described in Table 1. A phylogenetic tree was generated by maximum likelihood analysis by using PAUP (8)(Figure).
Not surprisingly, all of the isolates analyzed in this study contained the 3 nt mutations in the prM and E protein genes that differentiate the dominant genotype from other genotypes (prM-660[C to U]; E-1442[U to C]; E-2466[C to U]), which places each of the newly sequenced isolates in the dominant genotype clade relative to WN-NY99. Although several isolates shared additional mutations, most made up a large, indistinct polytomy with little branching and subclade formation. Most isolates from 2002 had the shortest branch lengths from the node separating the dominant clade from WN-NY99, which supports the hypothesis that the 2002 isolates represented the early stages of the emergence of the dominant genotype. The isolates from 2003, 2004, and 2005 had, on average, longer branch lengths than those of 2002, but few had >3 nt mutations from the dominant clade defining node, which suggests relative stasis in the divergence of the virus.
Of particular note was the presence of a subclade at the apical portion of the phylogenetic tree, composed of only isolates from 2005 and 2006. This distinct subclade was the result of a conserved silent nucleotide mutation at position E-2469(C to U), which had not been identified in any other publicly available WNV sequences (data not shown). The four 2005 isolates that were not included in this subclade (i.e., that do not have this mutation) were collected in the spring (March/April), while all other 2005 isolates were collected in early summer (June/July), suggesting that this mutation occurred during the 2005 WNV season but did not become fixed in the population until at least the beginning of the annual peak transmission period (June September). Alternatively, this mutation may have already been present in a vials introduced into the Houston area during early summer 2005. Regardless, the fixation of this mutation in isolates from 2005 and 2006 indicated its presence in the population at the start of intense WNV transmission in 2005, and it may have become fixed not as a result of positive selection or an increase in fitness but simply because it was present in those viruses that were subjected to an increased frequency of transmission during the early summer months.
To demonstrate the degree to which isolates have diverged from year to year, nucleotide sequences were grouped by year and the average pairwise distances between groups were calculated. Table 2 shows that the percent nucleotide divergence from WN-NY99 has generally increased over time (2002, 0.29%; 2006, 0.60%). Surprisingly, isolates from 2005 were on average slightly less divergent from WN-NY99 (0.45%) than were 2004 isolates (0.46%). Analysis of nucleotide sequence alignments showed that the 2005 isolates did not share any mutations with the 2004 isolates other than those denoting the dominant genotype (data not shown), which suggests that the 2005 isolates did not acquire mutations from viruses circulating during the previous transmission season. In addition, as shown in Table 2, the nucleotide divergence has marginally increased from year to year (2002-2003, 0.15%; 2003-2004, 0.32%; 2004-2005, 0.41%; 2005-2006, 0.48%). This finding indicates that, while WNV has continued to diverge, most mutations that occur each year are not passed on, and even viruses circulating in the same location continually diverge from 1 another if mutations are not fixed from year to year.
The relative stasis of the Houston metropolitan area WNV population and lack of newly emergent subclades containing 2002, 2003, and 2004 isolates suggest that few, if any, new genotypes of WNV from other regions of North America have been introduced locally and that the dominant genotype has been established and maintained in a local endemic transmission cycle. Additional sequence data from outside the Houston area collected during the same sampling period will be necessary to confirm or refute this hypothesis.
Of the 16 deduced amino acid substitutions that have occurred in the population studied (data not shown), only a single substitution (E159-Val to Ala) has become fixed, an indication that the dominant variant may be in a period of relative stasis. Only a single, silent nucleotide mutation has become fixed in the population since 2002, which indicates the infrequency of such molecular events and may reflect restrictions imposed on the genome; alternatively, it may indicate a lack of positive selective pressures acting on the virus population. During such intervals, if no fitness advantage is conferred by a particular substitution, random mutations may continue to accumulate at low frequencies, eventually giving rise to new subclades as a result of fixation. In this case, fixation may be due to the increased rate of transmission of a particular virus population during intensified transmission periods (i.e., after an increase in mosquito density), rather than in response to selective pressures or increased viral fitness. Thus, the forces driving the evolution of WNV may differ from location to location, and the newly described stasis of the Houston WNV population described in this study may or may not reflect similar trends in the continuing evolution of the virus in other regions of North America. Additionally, it is notable that there has been a lack of genetic divergence in an area lying on a major migratory bird flyway. The epidemiologic consequences of stasis within the Houston WNV population may have important implications for the endemicity of WNV disease in the Houston area and other similar locations.
We thank the University of Texas Medical Branch Protein Chemistry Laboratory for nucleic acid sequencing.
This research was supported in part by the James W. McLaughlin Fellowship Fund and National Institutes of Health (NIH) T32 award AI007536 (to C.T.D), NIH grant AI 67847 (to A.D.B.), and NIH contract NO1-AI25489 (to R.B.T.).
Dr Davis was a graduate research assistant at the University of Texas Medical Branch at the time of this study and is now a postdoctoral research fellow in the Influenza Division at the Centers for Disease Control and Prevention. His research interests include the molecular epidemiology and pathogenesis of flaviviruses and the evolution of influenza A viruses, in particular, the pandemic potential of avian/human influenza virus reassortants.
(1.) Davis CT, Beasley DCW, Guzman H, Raj P, D'Anton M, Novak RJ, et al. Genetic variation among temporally and geographically distinct West Nile virus isolates collected in the United States, 2001 and 2002. Emerg Infect Dis. 2003;9:1423-9.
(2.) Davis CT, Ebel GD, Lanciotti RS, Brault AC, Guzman H, Siirin M, et al. Phylogenetic analysis of North American West Nile virus isolates, 2001-2004: evidence for the emergence of a dominant genotype. Virology. 2005;342:252-65.
(3.) Ebel GD, Dupuis AP, Ngo K, Nicholas D, Kauffman E, Jones SA, et al. Partial genetic characterization of West Nile virus strains, New York State, 2000. Emerg Infect Dis. 2001;7:650-3.
(4.) Deardorff E, Estrada-Franco J, Brault AC, Navarro-Lopez R, Campomanes-Cortes A, Paz-Ramirez P, et al. Introductions of West Nile virus strains to Mexico. Emerg Infect Dis. 2006;12:314-8.
(5.) Beasley DW, Davis CT, Guzman H, Vanlandingham DL, Travassos da Rosa APA, Parsons R, et al. Limited evolution of West Nile virus has occurred during its southwesterly spread in the United States. Virology. 2003;309:190-5.
(6.) Ebel GD, Carricaburu JE, Young DS, Bernard KA, Kramer LD. Genetic and phenotypic variation of West Nile virus in New York, 2000 2003. Am J Trop Med Hyg. 2004;71:493-500.
(7.) Lillibridge KM, Parsons R, Randle Y, Travassos da Rosa APA, Guzman H, Siirin M. The 2002 introduction of West Nile virus into Harris County, TX, an area historically endemic for St. Louis encephalitis. Am J Trop Med Hyg. 2004;70:676-81.
(8.) Swofford DL. PAUP: phylogenetic analysis using parsimony, version 4. Sunderland (MA): Sinauer Academic Publishers; 2001.
Address for correspondence: Alan D. Barrett, Department of Pathology, University of Texas Medical Branch, 301 University Blvd, Galveston, TX 77555, USA; email: firstname.lastname@example.org
C. Todd Davis, * (1) Li Li, * Fiona J. May, * Rudy Bueno Jr, ([dagger]) James A. Dennett, ([dagger]) Adil A. Bala, ([dagger]) Hilda Guzman, * Darwin Elizondo-Quiroga, ([double dagger]) Robert B. Tesh, * and Alan D. Barrett *
* University of Texas Medical Branch, Galveston, Texas, USA; ([dagger]) Harris County Public Health and Environmental Services, Houston, Texas, USA; and ([double dagger]) Universidad Autonoma de Nuevo Leon, San Nicolas de Los Garza, Nuevo Leon, Mexico
(1) Current affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Table 1. West Nile virus isolates, Houston, Texas, 2002-2006 Year of GenBank Isolate isolation Source accession no. Bird 113 2002 Bluejay AY185906 Bird 114 2002 Bluejay AY185907 Bird 119 2002 Bluejay AY185908 Bird 123 2002 Hawk AY185909 Bird 135 2002 American crow AY185910 v1151 2002 Culex AY185911 quinquefasciatus Bird 227 2002 Bluejay AY185912 Bird 1519 2003 Bluejay DQ158227 Bird 1574 2003 Bluejay DQ158228 Bird 1576 2003 Bluejay DQ158229 Bird 1461 2003 Bluejay AY712947 Bird 1153 2003 Mourning dove AY712945 Bird 1171 2003 Great-tailed grackle AY712946 Bird 1175 2003 Bluejay DQ158220 Bird 1240 2003 Bluejay DQ158221 Bird 9045 2003 Bluejay DQ158223 Bird 9114 2003 Bluejay DQ158222 v4095 2003 C. quinquefasciatus DQ158224 v4369 2003 C. quinquefasciatus AY712948 v4096 2003 C. quinquefasciatus DQ158226 v4370 2003 C. quinquefasciatus DQ158225 Bird 2541 2004 C. quinquefasciatus DQ158234 Bird 2419 2004 Bluejay DQ158233 Bird 3588 2004 Bluejay DQ164206 Bird 3218 2004 Bluejay DQ158235 M8447 ([dagger]) 2004 C. restuans EF205419 M8451 ([dagger]) 2004 C. restuans EF205420 M8977 ([dagger]) 2004 C. restuans EF205421 Bird 4511 ([dagger]) 2005 American crow EF205422 Bird 4486 ([dagger]) 2005 American crow EF205423 Bird 4276 ([dagger]) 2005 Bluejay EF205424 Bird 4487 ([dagger]) 2005 American crow EF205425 Bird 5001 ([dagger]) 2005 Bluejay EF205426 Bird 5014 ([dagger]) 2005 Bluejay EF205427 Bird 5055 ([dagger]) 2005 House sparrow EF205428 Bird 5058 ([dagger]) 2005 Bluejay EF205429 M11769 ([dagger]) 2005 C. quinquefasciatus EF205430 M12214 ([dagger]) 2005 C. quinquefasciatus EF205431 M12251 ([dagger]) 2005 C. quinquefasciatus EF205432 M12357 ([dagger]) 2005 C. quinquefasciatus EF205433 M1977 ([dagger]) 2006 C. quinquefasciatus EF205434 Bird 5784 ([dagger]) 2006 Bluejay EF205435 Bird 5810 ([dagger]) 2006 Common grackle EF205436 M2766 ([dagger]) 2006 C. quinquefasciatus EF205437 * Isolates IS98STD1 (GenBank accession no. AF481864) and WN-NY99 (GenBank accession no. AF196835) were used during phylogenetic analysis. ([dagger]) Isolate was sequenced for this study. Table 2. Average pairwise percent nucleotide divergence between groups by year * ISR WN Group 1998 NY99 2002 2003 2004 2005 2006 ISR 1998 WIN NY99 0.20 2002 0.29 0.29 2003 0.36 0.36 0.15 2004 0.46 0.46 0.24 0.32 2005 0.45 0.45 0.24 0.31 0.41 2006 0.60 0.60 0.38 0.46 0.56 0.48 * ISR, Israel; WN, West Nile.
|Printer friendly Cite/link Email Feedback|
|Author:||Barrett, Alan D.|
|Publication:||Emerging Infectious Diseases|
|Date:||Apr 1, 2007|
|Previous Article:||Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006.|
|Next Article:||Autochthonous transmission of Trypanosoma cruzi, Louisiana.|